Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Fixed Capital/Sales

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.440.380.410.400.47

What is the latest Fixed Capital/Sales ratio of MARKSANS PHARMA ?

The latest Fixed Capital/Sales ratio of MARKSANS PHARMA is 0.44 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.44
Mar20230.38
Mar20220.41
Mar20210.40
Mar20200.47

How is Fixed Capital/Sales of MARKSANS PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.44
15.79
Mar2023 0.38
-7.32
Mar2022 0.41
2.50
Mar2021 0.4
-14.89
Mar2020 0.47 -

Other Financial Ratios of MARKSANS PHARMA


Compare Fixed Capital/Sales ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,485.0 Cr 3.6% -13.8% 85.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹443,661.0 Cr -1.8% 2.7% 49.1% Stock Analytics
DIVIS LABORATORIES ₹160,496.0 Cr -0.2% -3.4% 57% Stock Analytics
CIPLA ₹121,970.0 Cr -0.7% 0.6% 22.9% Stock Analytics
DR REDDYS LABORATORIES ₹112,877.0 Cr -1.8% 11.3% 18% Stock Analytics
ZYDUS LIFESCIENCES ₹98,163.2 Cr 1.9% 0.5% 41.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

3.6%

-13.8%

85.3%

SENSEX

0.7%

-2%

9.7%


You may also like the below Video Courses